Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Assets (2016 - 2021)

Syndax Pharmaceuticals has reported Return on Assets over the past 6 years, most recently at 0.08% for Q3 2021.

  • Quarterly results put Return on Assets at 0.08% for Q3 2021, up 27.0% from a year ago — trailing twelve months through Sep 2021 was 0.08% (up 27.0% YoY), and the annual figure for FY2025 was 0.4%, up 7.0%.
  • Return on Assets for Q3 2021 was 0.08% at Syndax Pharmaceuticals, up from 0.15% in the prior quarter.
  • Over the last five years, Return on Assets for SNDX hit a ceiling of 0.08% in Q3 2021 and a floor of 0.84% in Q4 2018.
  • Median Return on Assets over the past 5 years was 0.46% (2017), compared with a mean of 0.51%.
  • Biggest five-year swings in Return on Assets: plummeted -38bps in 2018 and later skyrocketed 52bps in 2020.
  • Syndax Pharmaceuticals' Return on Assets stood at 0.46% in 2017, then plummeted by -82bps to 0.84% in 2018, then increased by 2bps to 0.82% in 2019, then surged by 64bps to 0.3% in 2020, then soared by 73bps to 0.08% in 2021.
  • The last three reported values for Return on Assets were 0.08% (Q3 2021), 0.15% (Q2 2021), and 0.19% (Q1 2021) per Business Quant data.